Table 1.

Analysis of CYP1B1 expression


Tissue

Expression
Cancer  
    Acute lymphocytic leukemia* +++ 
    Acute myeloid leukemia*  +++  
    Breast cancer* +++ 
    Colon carcinoma*  +++  
    Esophagus carcinoma +++ 
    Lung cancer*  +++  
    Lymphoma* +++ 
    Multiple myeloma*  +++  
    Melanoma* +++ 
    Ovarian carcinoma*  +++  
    Rhabdomyosarcoma +++ 
Normal  
    Fallopian tube* +++ 
    Breast*  ++  
    Uterus (cervix, endometrium)* ++ 
    Ureter*  ++  
    Skin* + 
    Prostate*  +/-  
    Pancreas* +/- 
    Pituitary gland*  +/-  
    Colon* +/- 
    Bladder*  +/-  
    Small intestine* +/- 
    Thymus*  +/-  
    Adrenal gland* - 
    Blood cells*  -  
    Bone marrow* - 
    Cerebellum*  -  
    Cerebral cortex* - 
    Eye (retinal)*  -  
    Heart* - 
    Kidney (glomerulus, tubule)*  -  
    Liver* - 
    Lung*  -  
    Lymph node* - 
    Ovary*  -  
    Parathyroid* - 
    Placenta*  -  
    Skeletal muscle* - 
    Spinal cord*  -  
    Spleen* - 
    Stomach*  -  
    Testis* - 
    Thyroid*
 
-
 

Tissue

Expression
Cancer  
    Acute lymphocytic leukemia* +++ 
    Acute myeloid leukemia*  +++  
    Breast cancer* +++ 
    Colon carcinoma*  +++  
    Esophagus carcinoma +++ 
    Lung cancer*  +++  
    Lymphoma* +++ 
    Multiple myeloma*  +++  
    Melanoma* +++ 
    Ovarian carcinoma*  +++  
    Rhabdomyosarcoma +++ 
Normal  
    Fallopian tube* +++ 
    Breast*  ++  
    Uterus (cervix, endometrium)* ++ 
    Ureter*  ++  
    Skin* + 
    Prostate*  +/-  
    Pancreas* +/- 
    Pituitary gland*  +/-  
    Colon* +/- 
    Bladder*  +/-  
    Small intestine* +/- 
    Thymus*  +/-  
    Adrenal gland* - 
    Blood cells*  -  
    Bone marrow* - 
    Cerebellum*  -  
    Cerebral cortex* - 
    Eye (retinal)*  -  
    Heart* - 
    Kidney (glomerulus, tubule)*  -  
    Liver* - 
    Lung*  -  
    Lymph node* - 
    Ovary*  -  
    Parathyroid* - 
    Placenta*  -  
    Skeletal muscle* - 
    Spinal cord*  -  
    Spleen* - 
    Stomach*  -  
    Testis* - 
    Thyroid*
 
-
 

For normal tissues, tissue sections from 3 subjects were evaluated for CYP1B1 expression. Breast carcinoma was used as a positive control, always showing high expression. +++ indicates more than 20% of cells with high expression in all 3 normal samples; ++, intermediate expression, or less than 20% of cells with high expression in at least one sample; +, low expression, or less than 20% of cells with intermediate expression in at least one sample; +/-, weak expression in at least one sample; and -, no expression in any sample tested.

*

Tissues analyzed by immunohistochemistry (IHC).

Tissues analyzed by Western blot.

Analysis not performed on primary tumor tissue.

Close Modal

or Create an Account

Close Modal
Close Modal